Moreover, functional assays demonstrated that ECM-myCAFs reduce CD8 + T-cell cytotoxicity through a YAP1-dependent mechanism, suggesting an important role of YAP1 in myCAFs of BC. This evidence concerns the gene YAP1 and breast cancer.